BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37465377)

  • 1. Late mortality and causes of death among long-term survivors after autologous hematopoietic stem cell transplantation.
    Iida M; Nakasone H; Yamashita T; Inoue M; Ishida Y; Uchiyama H; Katayama Y; Miyamoto T; Yoshioka S; Shiratori S; Mori T; Sawa M; Sugio Y; Fukuda T; Ichinohe T; Atsuta Y; Inamoto Y;
    Blood Cell Ther; 2020 Feb; 3(1):11-17. PubMed ID: 37465377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A population-based cohort study of late mortality in adult autologous hematopoietic stem cell transplant recipients in Australia.
    Ashton LJ; Le Marsney RE; Dodds AJ; Nivison-Smith I; Wilcox L; O'Brien TA; Vajdic CM
    Biol Blood Marrow Transplant; 2014 Jul; 20(7):937-45. PubMed ID: 24631736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late Mortality and Causes of Death among Long-Term Survivors after Allogeneic Stem Cell Transplantation.
    Atsuta Y; Hirakawa A; Nakasone H; Kurosawa S; Oshima K; Sakai R; Ohashi K; Takahashi S; Mori T; Ozawa Y; Fukuda T; Kanamori H; Morishima Y; Kato K; Yabe H; Sakamaki H; Taniguchi S; Yamashita T;
    Biol Blood Marrow Transplant; 2016 Sep; 22(9):1702-1709. PubMed ID: 27246369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular events among recipients of hematopoietic stem cell transplantation-A systematic review and meta-analysis.
    Aghel N; Lui M; Wang V; Khalaf D; Mian H; Hillis C; Walker I; Leber B; Lipton JH; Aljama M; Lepic K; Berg T; Garcia-Horton A; Petropoulos J; Masoom H; Leong DP
    Bone Marrow Transplant; 2023 May; 58(5):478-490. PubMed ID: 36849807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant Transplantation-Related Mortality from Respiratory Virus Infections within the First One Hundred Days in Children after Hematopoietic Stem Cell Transplantation.
    Hutspardol S; Essa M; Richardson S; Schechter T; Ali M; Krueger J; Fujii H; Egeler RM; Gassas A
    Biol Blood Marrow Transplant; 2015 Oct; 21(10):1802-7. PubMed ID: 26117558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late mortality after hematopoietic SCT for a childhood malignancy.
    Schechter T; Pole JD; Darmawikarta D; Doyle J; Ali M; Egeler M; Gassas A; Irwin MS; Greenberg M; Nathan PC
    Bone Marrow Transplant; 2013 Oct; 48(10):1291-5. PubMed ID: 23665822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens.
    Abou-Mourad YR; Lau BC; Barnett MJ; Forrest DL; Hogge DE; Nantel SH; Nevill TJ; Shepherd JD; Smith CA; Song KW; Sutherland HJ; Toze CL; Lavoie JC
    Bone Marrow Transplant; 2010 Feb; 45(2):295-302. PubMed ID: 19597425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Second allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and donor changes in relapsed hematological malignancies after the first allogeneic transplant].
    Zhao YQ; Song YZ; Li ZH; Yang F; Xu T; Li FF; Yang DF; Wu T
    Zhonghua Xue Ye Xue Za Zhi; 2023 Jun; 44(6):465-471. PubMed ID: 37550201
    [No Abstract]   [Full Text] [Related]  

  • 9. Late Kidney Morbidity and Mortality in Hematopoietic Cell Transplant Survivors.
    Wu NL; Hingorani S; Cushing-Haugen KL; Lee SJ; Chow EJ
    Transplant Cell Ther; 2021 May; 27(5):434.e1-434.e6. PubMed ID: 33775588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival of patients with mantle cell lymphoma after autologous haematopoietic stem-cell transplantation in first remission: a post-hoc analysis of an open-label, multicentre, randomised, phase 3 trial.
    Zoellner AK; Unterhalt M; Stilgenbauer S; Hübel K; Thieblemont C; Metzner B; Topp M; Truemper L; Schmidt C; Bouabdallah K; Krauter J; Lenz G; Dürig J; Vergote V; Schäfer-Eckart K; André M; Kluin-Nelemans HC; van Hoof A; Klapper W; Hiddemann W; Dreyling M; Hoster E;
    Lancet Haematol; 2021 Sep; 8(9):e648-e657. PubMed ID: 34450102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease.
    Atsuta Y; Suzuki R; Yamashita T; Fukuda T; Miyamura K; Taniguchi S; Iida H; Uchida T; Ikegame K; Takahashi S; Kato K; Kawa K; Nagamura-Inoue T; Morishima Y; Sakamaki H; Kodera Y;
    Ann Oncol; 2014 Feb; 25(2):435-41. PubMed ID: 24399081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study.
    Sharma A; Bhatt NS; St Martin A; Abid MB; Bloomquist J; Chemaly RF; Dandoy C; Gauthier J; Gowda L; Perales MA; Seropian S; Shaw BE; Tuschl EE; Zeidan AM; Riches ML; Shah GL
    Lancet Haematol; 2021 Mar; 8(3):e185-e193. PubMed ID: 33482113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study.
    Bhatia S; Robison LL; Francisco L; Carter A; Liu Y; Grant M; Baker KS; Fung H; Gurney JG; McGlave PB; Nademanee A; Ramsay NK; Stein A; Weisdorf DJ; Forman SJ
    Blood; 2005 Jun; 105(11):4215-22. PubMed ID: 15701723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term Survival after Hematopoietic Cell Transplant for Sickle Cell Disease Compared to the United States Population.
    St Martin A; Hebert KM; Serret-Larmande A; Jouhet V; Hughes E; Stedman J; DeSain T; Pillion D; Lyons JC; Steinert P; Avillach P; Eapen M
    Transplant Cell Ther; 2022 Jun; 28(6):325.e1-325.e7. PubMed ID: 35302009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.
    Cavo M; Gay F; Beksac M; Pantani L; Petrucci MT; Dimopoulos MA; Dozza L; van der Holt B; Zweegman S; Oliva S; van der Velden VHJ; Zamagni E; Palumbo GA; Patriarca F; Montefusco V; Galli M; Maisnar V; Gamberi B; Hansson M; Belotti A; Pour L; Ypma P; Grasso M; Croockewit A; Ballanti S; Offidani M; Vincelli ID; Zambello R; Liberati AM; Andersen NF; Broijl A; Troia R; Pascarella A; Benevolo G; Levin MD; Bos G; Ludwig H; Aquino S; Morelli AM; Wu KL; Boersma R; Hajek R; Durian M; von dem Borne PA; Caravita di Toritto T; Zander T; Driessen C; Specchia G; Waage A; Gimsing P; Mellqvist UH; van Marwijk Kooy M; Minnema M; Mandigers C; Cafro AM; Palmas A; Carvalho S; Spencer A; Boccadoro M; Sonneveld P
    Lancet Haematol; 2020 Jun; 7(6):e456-e468. PubMed ID: 32359506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleuroparenchymal fibroelastosis after hematopoietic stem cell transplantation in children: a propensity score-matched analysis.
    Oh SL; Lee JW; Yoo SY; Kim JH; Kim YJ; Han J; Kim K; Kim J; Jeon TY
    Eur Radiol; 2023 Mar; 33(3):2266-2276. PubMed ID: 36346442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of secondary solid malignancies after allogeneic hematopoietic stem cell transplantation and preventive strategies.
    Adhikari J; Sharma P; Bhatt VR
    Future Oncol; 2015; 11(23):3175-85. PubMed ID: 26551415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation.
    Kliman D; Nivison-Smith I; Gottlieb D; Hamad N; Kerridge I; Purtill D; Szer J; Ma D
    Biol Blood Marrow Transplant; 2020 Sep; 26(9):1711-1718. PubMed ID: 32194285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health status, late effects and long-term survivorship of allogeneic bone marrow transplantation: a retrospective study.
    Gifford G; Sim J; Horne A; Ma D
    Intern Med J; 2014 Feb; 44(2):139-47. PubMed ID: 24320824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.